Erratum for Dorr et al., J Clin Oncol 19 (6) 1589-1599.
Erratum for Voogd et al., J Clin Oncol 19 (6) 1688-1697.
Erratum for Sharma et al., J Clin Oncol 19 (6) 1839-1847.
Erratum for Bilchik et al., J Clin Oncol 19 (4) 1128-1136.
Erratum for Soiffer et al., J Clin Oncol 19 (4) 1152-1159.

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

The second sentence in the legend for Figure 1 should read: "Within 30 to 60 seconds, the blue dye traveled from the primary site along the lymphatic channel (arrow) to the SN(s) (arrowheads).

In the February 15, 2001, article by Soiffer et al, entitled "CD6+ Donor Marrow T-Cell Depletion as the Sole Form of Graft-Versus-Disease Prophylaxis in Patients Undergoing Allogeneic Bone Marrow Transplant From Unrelated Donors" (J Clin Oncol 19:1152-1159, 2001), there is an error in the abstract.

In the Patients and Methods section of the abstract, the fourth sentence should read: "To facilitate engraftment, patients also received 7.5 Gy (22 patients) or 4.5 Gy (26 patients) of total lymphoid irradiation (TLI) before admission."

In the March 15, 2001, issue, the abstract of the article by Dorr et al, entitled "Phase I/II Study of the P-Glycoprotein Modulator PSC 833 in Patients With Acute Myeloid Leukemia" (J Clin Oncol 19:1589-1599, 2001), contained an error.

In the Patients and Methods section of the abstract, the second sentence should read: "Daunorubicin was administered as a 72-hour continuous infusion at 34 or 45 mg/m²/d."

In the March 15, 2001, article by Voogd et al, entitled "Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials" (J Clin Oncol 19:1688-1697, 2001), the corresponding author’s email address is incorrect.

The correct email address for Dr Joop van Dongen is j.v.dongen@ikz.nl.

In the March 15, 2001, article by Sharma et al, entitled "Development of Inhalational Agents for Oncologic Use" (J Clin Oncol 19:1839-1847, 2001), the footnote section, including the authors’ affiliations and contact information, was inadvertently omitted. The footnote section should have read as follows:

From the Memorial Sloan-Kettering Cancer Center, New York, NY; University of Wisconsin Comprehensive Cancer Center, Madison, WI; and Battelle Pulmonary Therapeutics, Columbus, OH.

Submitted August 11, 2000; accepted December 7, 2000.

Address reprint requests to Sunil Sharma, MD, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021.

The publisher regrets these errors.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?